Front-line chronic lymphocytic leukemia: The role of chemoimmunotherapy

被引：5
|
作者：
Kim, Myung Sun [1 ,3 ]
Prasad, Vinay [2 ]
机构：
[1] Compass Oncol, Med Oncol Hematol, Portland, OR USA
[2] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA USA
[3] Compass Oncol, Hematol Med Oncol, 5050 NE Hoyt St,Suite 256, Portland, OR 97213 USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2023年 / 98卷 / 04期
关键词：
D O I：
10.1002/ajh.26864
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：560 / 561
页数：2
相关论文
共 50 条
  • [31] Current Treatment of Chronic Lymphocytic Leukemia: The Diminishing Role of Chemoimmunotherapy
    Roeker, Lindsey E.
    Thompson, Meghan
    Mato, Anthony R.
    DRUGS, 2022, 82 (02) : 133 - 143
  • [32] Current Treatment of Chronic Lymphocytic Leukemia: The Diminishing Role of Chemoimmunotherapy
    Lindsey E. Roeker
    Meghan Thompson
    Anthony R. Mato
    Drugs, 2022, 82 : 133 - 143
  • [33] The Impact of Front-Line Ibrutinib Dose Reduction and Interruption on Outcomes in Chronic Lymphocytic Leukemia (CLL) Patients
    Rhodes, Joanna
    Barr, Paul M.
    Ujjani, Chaitra S.
    Nabhan, Chadi
    Tam, Constantine S.
    Jacobs, Ryan
    Lansigan, Frederick
    Hill, Brian T.
    Brander, Danielle M.
    Shadman, Mazyar
    Skarbnik, Alan P.
    Pu, Jeffrey J.
    Sehgal, Alison R.
    Pagel, John M.
    Allan, John N.
    Kennard, Kaitlin
    Cheson, Bruce D.
    Beach, Douglas F.
    Patel, Bhavisha
    Isaac, Krista
    Tuncer, Hande H.
    Furman, Richard R.
    Mato, Anthony R.
    BLOOD, 2017, 130
  • [34] Historical Trends in the Front-Line Treatment in Patients With Chronic Lymphocytic Leukemia: Experience from a European Center
    Arguello-Tomas, Miguel
    Albiol, Nil
    Jara, Paola
    Sierra, Jordi
    Mora, Alba
    Moreno, Carol
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S280 - S280
  • [35] Front-line treatment of patients with chronic lymphocytic leukemia: a systematic review and network meta-analysis
    Xu, Yingxin
    Fahrbach, Kyle
    Dorman, Emily
    Baculea, Simona
    Cote, Sarah
    van Sanden, Suzy
    Diels, Joris
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2018, 7 (05) : 421 - 441
  • [36] Time-to-progression after front-line fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy for chronic lymphocytic leukaemia: a retrospective, multicohort study
    Herling, Carmen D.
    Coombes, Kevin R.
    Benner, Axel
    Bloehdorn, Johannes
    Barron, Lynn L.
    Abrams, Zachary B.
    Majewski, Tadeusz
    Bondaruk, Jolanta E.
    Bahlo, Jasmin
    Fischer, Kirsten
    Hallek, Michael
    Stilgenbauer, Stephan
    Czerniak, Bogdan A.
    Oakes, Christopher C.
    Ferrajoli, Alessandra
    Keating, Michael J.
    Abruzzo, Lynne V.
    LANCET ONCOLOGY, 2019, 20 (11): : 1576 - 1586
  • [37] FRONT-LINE THERAPY WITH CHLORAMBUCIL PLUS RITUXIMAB IN ELDERLY AND/OR UNFIT PATIENTS AFFECTED BY CHRONIC LYMPHOCYTIC LEUKEMIA
    Innocenti, I.
    Tarnani, M.
    Vannata, B.
    De Padua, L.
    Santini, F.
    Marietti, S.
    Za, T.
    Bellesi, S.
    Autore, F.
    Chiusolo, P.
    Sora, F.
    Sica, S.
    Leone, G.
    Laurenti, L.
    HAEMATOLOGICA, 2012, 97 : 523 - 524
  • [38] Fine-tuning front-line therapy in chronic lymphocytic leukemia News from ASH 2019
    Bohn, Jan-Paul
    Wolf, Dominik
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2020, 13 (03) : 259 - 265
  • [39] Chronic Lymphocytic Leukemia: Chemoimmunotherapy is over? No
    Eichhorst, Barbara
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S120 - S122
  • [40] Chemoimmunotherapy for Chronic Lymphocytic Leukemia REPLY
    Goede, Valentin
    Fischer, Kirsten
    Hallek, Michael
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (24): : 2348 - 2349
12345